Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: The PERSEVERE Study [NA]

View source ↗

Summary

The PERSEVERE Study by Inari Medical is currently recruiting to evaluate treatment for pulmonary embolism using the FlowTriever System.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FlowTriever System

Snippet

Sponsor: Inari Medical | Conditions: Pulmonary Embolism, Pulmonary Thromboembolism | NA | Status: RECRUITING